ALYSSA HALEVY: Open Payments
NPI 1902392467 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 9 payments from 4 companies in 2025. Trend: 2023 $16 · 2024 $341 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $68 |
| GENZYME CORPORATION | 3 | $59 |
| ABBVIE INC. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: DUPIXENT, NUCALA, LUMIGAN.
Industry payments across NJ — which companies pay providers there.
